A Win For Diffusion Pharmaceuticals Inc.
Fri, May 15, 2020 at 05:34 PM
Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ) shot up at $1.35, a gain of 32.4%. On Thu 14 May 20, DFFN:NASDAQ touched a New 2-Week High of $1.02. The stock appeared on our News Catalysts scanner on Thu 14 May 20 at 05:52 PM in the 'INVESTOR UPDATE' category. From Thu 30 Apr 20, the stock recorded 80.00% Up Days and 63.64% Green Days
About Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ)
Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy.
Top 10 Gainers:
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 158.02%
- Aurora Cannabis Inc. (ACB:NYSE), 68.67%
- Torchlight Energy Resources, Inc. (TRCH:NASDAQ), 48.28%
- Sundial Growers Inc. (SNDL:NASDAQ), 42.08%
- Alta Equipment Group Inc. (ALTG:NYSE), 35.27%
- Tenax Therapeutics, Inc. (TENX:NASDAQ), 33.63%
- Tetraphase Pharmaceuticals, Inc. (TTPH:NASDAQ), 33.54%
- CRDF (CRDF:NASDAQ), 32.87%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 32.35%
- Seelos Therapeutics, Inc. (SEEL:NASDAQ), 31.08%